Hybrid 2-aminoterailin and aryl-substituted piperazine compounds and their use in altering CNS activity

Hybrid compounds containing an aminotetralin moiety or a heterocyclic and/or open chain analog thereof linked through an alkylene group to an aryl ring system-substituted piperidiene moiety exhibit high levels of CNS activity, in some cases exhibiting especially high relative binding efficiencies between D3 and D2 dopaminergic receptor subtypes.

Patents:
US 7,723,519

Inventor(s): DUTTA ALOKE K [US]

Type of Offer: Licensing



« More Biotech Patents

---